---
title: "DOTI Micro released its first-quarter performance, with a net profit attributable to the parent company of 20.098 million yuan, an increase of 155.43%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236831985.md"
description: "DOTI Micro released its Q1 2025 performance, with operating revenue of 156 million yuan, a year-on-year increase of 26.88%; net profit attributable to the parent company of 20.098 million yuan, a year-on-year increase of 155.43%; net profit excluding non-recurring gains and losses of 19.7656 million yuan, a year-on-year increase of 156.99%; basic earnings per share of 0.25 yuan"
datetime: "2025-04-21T16:36:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236831985.md)
  - [en](https://longbridge.com/en/news/236831985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236831985.md)
---

# DOTI Micro released its first-quarter performance, with a net profit attributable to the parent company of 20.098 million yuan, an increase of 155.43%

According to the Zhitong Finance APP, DOTI Micro (301183.SZ) released its first-quarter report for 2025, with operating revenue of 156 million yuan, a year-on-year increase of 26.88%. The net profit attributable to shareholders of the listed company was 20.098 million yuan, a year-on-year increase of 155.43%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 19.7656 million yuan, a year-on-year increase of 156.99%. The basic earnings per share were 0.25 yuan

### Related Stocks

- [301183.CN](https://longbridge.com/en/quote/301183.CN.md)

## Related News & Research

- [How the SEC is clearing the path for more companies to go public](https://longbridge.com/en/news/294409345.md)
- [Malaysian billionaire Syed Mokhtar Albukhary's IPO plan for property developer WM Senibong reportedly faces hurdles](https://longbridge.com/en/news/294572752.md)
- [S’pore must deepen ASEAN links as business costs rise: report](https://longbridge.com/en/news/294641573.md)
- [Fresenius says FDA, EMA accept Vedolizumab biosimilar PB016 filings for review](https://longbridge.com/en/news/294463337.md)
- [Iran issues Gulf-wide energy hit list if Trump carries through on threats to destroy Iran’s energy sector](https://longbridge.com/en/news/294609891.md)